Skip to main content

Find Clinical Trials

Home
Conditions
Otorhinolaryngologic Diseases

Clinical trial condition

Otorhinolaryngologic Diseases

Explore clinical trials studying Otorhinolaryngologic Diseases. Study availability and eligibility vary by location and protocol.

5,434 public trials 864 recruiting studies

Refine in advanced search Browse all conditions

Otorhinolaryngologic Diseases trial results

Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

NCT00163501

Conditions: Allergic Rhinitis, Hay Fever, Hypersensitivity, +11 more
Locations: Altana Pharma/Nycomed Encinitas, California, United States

Altana Pharma/Nycomed Huntington Beach, California, United States

Altana Pharma/Nycomed Long Beach, California, United States

Altana Pharma/Nycomed Los Angeles, California, United States

View all 41 locations

View Trial Details

Completed

Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)

NCT00305487

Conditions: Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +9 more
Locations: Altana Pharma/Nycomed Birmingham, Alabama, United States

Altana Pharma/Nycomed Hot Springs, Arkansas, United States

Altana Pharma/Nycomed Costa Mesa, California, United States

Altana Pharma/Nycomed Huntington Beach, California, United States

View all 71 locations

View Trial Details

Completed

Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)

NCT00261287

Conditions: Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +10 more
Locations: Altana Pharma/Nycomed Long Beach, California, United States

Altana Pharma/Nycomed Normal, Illinois, United States

Altana Pharma/Nycomed San Antonio, Texas, United States

View Trial Details

Completed

Benefit From the Chin Down Maneuver in the Swallowing Performance and Self-perception of Parkinson's Disease Patients

NCT02973698

Conditions: Basal Ganglia Diseases, Behavior, Brain Diseases, +25 more
Locations: Not specified

View Trial Details

Completed

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

NCT00806754

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: Altana/Nycomed Encinitas, California, United States

Altana/Nycomed Los Angeles, California, United States

Altana/Nycomed Mission Viejo, California, United States

Altana/Nycomed San Diego, California, United States

View all 35 locations

View Trial Details

Completed

Real-World Benefit From Directional Hearing Aids

NCT00438334

Conditions: Ear Diseases, Hearing Disorders, Hearing Loss, +6 more
Locations: Department of Veterans Affairs Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber

NCT01804400

Conditions: Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
Locations: Novartis Investigative Site Hanover, Germany

View Trial Details

Completed

A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber

NCT00784732

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: Novartis Investigator Site Toronto, Canada

View Trial Details

Completed

Family MobilePhone Otoscopy in Diagnostics of Otitis Media

NCT02452164

Conditions: Ear Diseases, Otitis, Otitis Media, +1 more
Locations: Turku University Hospital Turku, Finland

View Trial Details

Completed

Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma

NCT02963896

Conditions: Cranial Nerve Diseases, Cranial Nerve Neoplasms, Ear Diseases, +19 more
Locations: Not specified

View Trial Details